ArticleInternational journal of clinical oncology2015

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.

Hiroaki Itamochi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.